NEW YORK, July 3 NY-Mergent-Inc-index
NEW YORK, July 3 /PRNewswire/ -- Mergent, Inc., administrator for the
HealthShares(TM) Indexes, a series of 20 underlying indexes for the
HealthShares(TM) Exchange Traded Funds, today announced the following change
effective on the opening of trading on Wednesday July 9, 2008: ISTA
Pharmaceuticals (Nasdaq: ISTA) will replace Jerini AG (Frankfurt, Germany:
JI4) in the HealthShares(TM) Ophthalmology Index. Jerini AG is being acquired
by Shire Limited (London Main Market, U.K.: SHP LO).
(Logo: http://www.newscom.com/cgi-bin/prnh/20080204/CLM073LOGO )
Companies included in the HealthShares(TM) Ophthalmology Index are engaged
in the research, clinical development and/or commercialization of therapeutic
agents by means of pharmaceuticals, medical devices or biomaterials for the
treatment of various diseases of the eye including, but not limited to,
age-related macular degeneration, dry-eye, diabetic macular edema, glaucoma,
presbyopia and myopia.
About Mergent
Mergent, Inc., a Xinhua Finance company (TSE Mothers: 9399; OTC ADRs:
XHFNY), is the preferred provider of business and financial data on global
publicly listed companies. Headquartered in Fort Mill, SC and New York City
with sales offices in key North American cities, Mergent also has a strong
global presence with offices in London, Shanghai, Tokyo, and Melbourne.
Mergent's databases contain detailed financial information on over 35,000
global publicly traded companies from more than 100 countries, 2.2 million
U.S. municipal bond issues, 117,000 corporates, and extensive data on
dividends, corporate actions and unit investment trusts. Mergent products are
unique in the provision of rich textual historical data in financial
instruments dating back to the early 1900s.
For more information, please visit http://www.mergent.com and
http://www.dividendachievers.com .
SOURCE Mergent, Inc.
